A Multicenter Observational Study Of Effectiveness And Safety Of Nivolumab In Non-Small Cell Lung Cancer In Real Clinical Practice.

Juan Francisco Marín Pozo,Macarena Merino Almazán,Juan Manuel Duarte Pérez, Facundo Alberti Vargas, María Paz Quesada Sanz, Begoña Muros de Fuentes,María Teresa Garrido Martínez,Margarita Garrido Siles,María José Martínez Bautista, Carmen Martínez Díaz,Ana I. Sánchez,José Carlos Roldán Morales, Pablo Nieto Guindo, Silvia Maria Artacho Criado,María Dolores Alvarado Fernández, Beatriz Mora Rodríguez,Fátima Artime-Rodríguez-Hermida,Pedro Sánchez Rovira

JOURNAL OF CLINICAL ONCOLOGY（2018）

引用 0|浏览10

暂无评分

摘要

e21092Background: Nivolumab is recommended as a standard-of-care treatment in patients (pts) with progression to first-line therapy for non-smal-cell lung cancer (NSCLC). Our objective is to evalua...

查看译文

关键词

nivolumab,lung cancer,non-small

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要